Skip to main content

Table 1 Characteristics of the study participants (N = 384)

From: Association of predicted 10 years cardiovascular mortality risk with duration of HIV infection and antiretroviral therapy among HIV-infected individuals in Durban, South Africa

Characteristics

N

All patients (mean ± SD)

Men (mean ± SD)

Women (mean ± SD)

P-value i

Age (years)

384

42.82 (8.3)

43.26 (8.2)

42.54 (8.4)

0.121

HIV infection duration (years)

220

6.33 (3.9)

5.78 (4.0)

6.72 (3.9)

0.047*

ART duration (years)

383

6.18 (3.43)

5.82 (3.5)

6.39 (3.4)

0.094#

CD4 cell counts (cells/µL)

364

407.5 (254.6)

347.9 (207.2)

437.9 (271.0)

0.005**

Height (metres)

270

162.7 (9.2)

169.1 (9.6)

159.5 (7.2)

< 0.001**

Weight (Kg)

377

70.8 (17.0)

69.1 (14.0)

71.7 (18.3)

0.324

BMI (kg/m2)

270

26.5 (6.8)

23.7 (5.7)

27.9 (6.8)

< 0.001**

Systolic blood pressure (mmHg)

206

120.3 (19.8)

129.7 (25.7)

118.2 (17.3)

0.052#

Diastolic blood pressure (mmHg)

207

80.6 (55.0)

79.8 (18.1)

80.9 (63.5)

0.191

Blood glucose (mmol/L)

246

5.6 (2.4)

5.8 (2.4)

5.5 (2.5)

0.012*

Triglycerides (mmol/L)

111

1.6 (1.1)

1.9 (1.4)

1.5 (0.9)

0.096#

HDL cholesterol (mmol/L)

112

1.3 (0.4)

1.2 (0.3)

1.3 (0.4)

0.194

  1. i: Wilcoxon rank-sum test; **: significant at 1% level; *: significant at 5% level; #: significant at 10% level